Brief: Reneo Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
23/03/2022 20:26
March 23 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.43
* CASH RUNWAY SUFFICIENT TO FUND PLANNED OPERATIONS INTO
2024
Source text for Eikon: ID:nGNX8661CN
Further company coverage: RPHM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker